Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2017, Article ID 1847428, 7 pages
https://doi.org/10.1155/2017/1847428
Case Report

Liver Metastases in Pancreatic Acinar Cell Carcinoma Treated with Selective Internal Radiation Therapy with Y-90 Resin Microspheres

1Interventional Radiology Unit, Hospital Israelita Albert Einstein, Av. Albert Einstein 627/701, Morumbi, 05652-900 São Paulo, SP, Brazil
2Pathology Department, Hospital Israelita Albert Einstein, Av. Albert Einstein 627/701, Morumbi, 05652-900 São Paulo, SP, Brazil
3Nuclear Medicine Unit, Hospital Israelita Albert Einstein, Av. Albert Einstein 627/701, Morumbi, 05652-900 São Paulo, SP, Brazil
4Oncology Department, Hospital Israelita Albert Einstein, Av. Albert Einstein 627/701, Morumbi, 05652-900 São Paulo, SP, Brazil
5Cardiology Department, Hospital Israelita Albert Einstein, Av. Albert Einstein 627/701, Morumbi, 05652-900 São Paulo, SP, Brazil
6General and Oncological Surgery, Hospital Israelita Albert Einstein, Av. Albert Einstein 627/701, Morumbi, 05652-900 São Paulo, SP, Brazil

Correspondence should be addressed to Joaquim Maurício Motta Leal Filho; rb.moc.oohay@fuamatoj

Received 24 April 2017; Accepted 10 September 2017; Published 11 October 2017

Academic Editor: Melanie Deutsch

Copyright © 2017 Felipe Nasser et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Mulkeen, P. S. Yoo, and C. Cha, “Less common neoplasms of the pancreas,” World Journal of Gastroenterology, vol. 12, no. 20, pp. 3180–3185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Chaudhary, “Acinar cell carcinoma of the pancreas: a literature review and update,” Indian Journal of Surgery, vol. 77, no. 3, pp. 226–231, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. D. Holen, D. S. Klimstra, A. Hummer et al., “Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors,” Journal of Clinical Oncology, vol. 20, no. 24, pp. 4673–4678, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Lowery, D. S. Klimstra, J. Shia et al., “Acinar cell carcinoma of the pancreas: New genetic and treatment insights into a rare malignancy,” Oncologist, vol. 16, no. 12, pp. 1714–1720, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Bester, B. Meteling, N. Pocock, A. Saxena, T. C. Chua, and D. L. Morris, “Radioembolisation with Yttrium-90 microspheres: An effective treatment modality for unresectable liver metastases,” Journal of Medical Imaging and Radiation Oncology, vol. 57, no. 1, pp. 72–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. Lewandowski, J.-F. Geschwind, E. Liapi, and R. Salem, “Transcatheter intraarterial therapies: Rationale and overview,” Radiology, vol. 259, no. 3, pp. 641–657, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Gulec, K. Pennington, J. Wheeler et al., “Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (Chemo-SIRT) for colorectal cancer liver metastases: An in vivo double-arm-controlled phase II trial,” American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 36, no. 5, pp. 455–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. W. Lee, A. S. Thakor, B. A. Tafti, and D. M. Liu, “Y90 Selective Internal Radiation Therapy,” Surgical Oncology Clinics of North America, vol. 24, no. 1, pp. 167–185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Saxena, T. C. Chua, L. Bester, A. Kokandi, and D. L. Morris, “Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: A critical appraisal of 48 cases,” Annals of Surgery, vol. 251, no. 5, pp. 910–916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Khajornjiraphan, N. A. Thu, and P. K. Chow, “Yttrium-90 microspheres: a review of its emerging clinical indications,” Liver Cancer, vol. 4, no. 1, pp. 6–15, 2015. View at Publisher · View at Google Scholar
  11. M. Michl, A. R. Haug, T. F. Jakobs et al., “Radioembolization with yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors,” Oncology, vol. 86, no. 1, pp. 24–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. T. X. Yang, T. C. Chua, and D. L. Morris, “Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - A systematic review,” Surgical Oncology, vol. 21, no. 4, pp. 299–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Y. Kim, K. Unger, H. Wang, and M. J. Pishvaian, “Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience,” BMC Cancer, vol. 16, no. 1, article 492, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Loree, T. Hiruki, and H. F. Kennecke, “Case report of cirrhosis following yttrium-90 radioembolization for pancreatic neuroendocrine liver metastases,” Case Reports in Oncology, vol. 9, no. 1, pp. 76–82, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Fidelman, R. K. Kerlan, R. A. Hawkins et al., “Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: Final report of a prospective pilot study,” Journal of Gastrointestinal Oncology, vol. 7, no. 6, pp. 860–874, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Gordon, O. Uddin, A. Riaz, R. Salem, and R. Lewandowski, “Making the case: intra-arterial therapy for less common metastases,” Seminars in Interventional Radiology, vol. 34, no. 02, pp. 132–139, 2017. View at Publisher · View at Google Scholar
  17. A. Kennedy, S. Nag, and R. Salem, “Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium,” International Journal of Radiation Oncology, Biology, Physics, vol. 68, no. 1, pp. 13–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. SIR-Spheres® microspheres (Yttrium-90 Microspheres), Sirtex Medical Limited, North Sydney, New South Wales, Australia, 2014.
  19. E. A. Eisenhauer, P. Therasse, J. Bogaerts et al., “New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1),” European Journal of Cancer, vol. 45, no. 2, pp. 228–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Tian, X. F. Lv, J. Dong et al., “Clinical features and CT/MRI findings of pancreatic acinar cell carcinoma,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 9, pp. 14846–14854, 2015. View at Google Scholar
  21. M. Michl, S. Lehner, P. M. Paprottka et al., “Use of PERCIST for prediction of progression-free and overall survival after radioembolization for liver metastases from pancreatic cancer,” Journal of Nuclear Medicine, vol. 57, no. 3, pp. 355–360, 2016. View at Publisher · View at Google Scholar · View at Scopus